UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes

Annals of internal medicine, 2016-04, Vol.164 (8), p.542

2016

Volltextzugriff (PDF)

User's guide to mechanism of action and clinical use of GLP-1 receptor agonists

Postgraduate medicine, 2015-01, Vol.127 (8), p.818-826

2015

Volltextzugriff (PDF)

Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies

Clinical diabetes, 2016-04, Vol.34 (2), p.81-85

Shaefer, Jr, Charles F

2016

Volltextzugriff (PDF)

Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus

Diabetes therapy, 2017-02, Vol.8 (1), p.33-53

2017

Volltextzugriff (PDF)

Commentary: Exenatide QW: A New Treatment Option for Type 2 Diabetes Offering Ease of Use, Improved Efficacy, and Reduced Side Effects

Clinical diabetes, 2012-06, Vol.30 (3), p.92-94

Shaefer, Charles F., Jr

2012

Volltextzugriff (PDF)

The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin

Postgraduate medicine, 2016-01, Vol.128 (1), p.137-144

2016

Volltextzugriff (PDF)

Weight Change in Patients with Type 2 Diabetes Starting Basal Insulin Therapy: Correlates and Impact on Outcomes

Postgraduate medicine, 2014-10, Vol.126 (6), p.93-104

2014

Volltextzugriff (PDF)

Evaluation of an adrenal mass in a patient with progressive prostate cancer reveals pheochromocytoma

International journal of urology, 2006-06, Vol.13 (6), p.798-800

2006

Volltextzugriff (PDF)

Using a Quantitative Measure of Diabetes Risk in Clinical Practice to Target and Maximize Diabetes Prevention Interventions

Clinical diabetes, 2013-03, Vol.31 (2), p.82-89

2013

Volltextzugriff (PDF)

LOU064 : un inhibiteur covalent oral de la BTK hautement sélectif et puissant avec des effets pharmacodynamiques prometteurs au niveau de la peau

Annales de dermatologie et de vénéréologie, 2020-12, Vol.147 (12), p.A345-A345

2020

Volltextzugriff (PDF)

The Good Old Days Were Not So Good for Inpatient Care

Insulin, 2007, Vol.2 (1), p.2-3

Shaefer, Charles F

2007

Volltextzugriff (PDF)

Insulin and Type 2 Diabetes Mellitus Treatment Today: Are We at a Tipping Point?

Insulin, 2007-07, Vol.2 (3), p.106-108

Shaefer, Jr, Charles F.

2007

Volltextzugriff (PDF)

In search of the holy grail? The quest to reduce macrovascular disease in type 2 diabetes mellitus

Insulin, 2010, Vol.5 (1), p.2-6

Shaefer, Charles F.

2010

Volltextzugriff (PDF)

The pen is mightier than the sword

Insulin, 2009-07, Vol.4 (3), p.132-135

Shaefer, Charles F.

2009

Volltextzugriff (PDF)

The perfect storm?

Insulin, 2009, Vol.4 (2), p.84-86

Shaefer, Charles F.

2009

Volltextzugriff (PDF)

Shopping for basal insulin on the coffee aisle: Lots of choices for lots of tastes

Insulin, 2008-07, Vol.3 (3), p.146-149

Shaefer, Charles F.

2008

Volltextzugriff (PDF)

Implications of the ADA/EASD consensus algorithm for treatment of type 2 diabetes mellitus for primary care practitioners: Four pivotal points

Insulin, 2008-04, Vol.3, p.126-131

Shaefer, Charles F.

2008

Volltextzugriff (PDF)

Sunshine on a rainy day: Good news for diabetes

Insulin, 2008-04, Vol.3 (2), p.56-58

Shaefer, Charles F.

2008

Volltextzugriff (PDF)

Patient and Physician Barriers to Instituting Insulin Therapy: A Case-Based Overview

Insulin, 2007-11, Vol.2, p.S41-S46

Shaefer, Charles F.

2007

Volltextzugriff (PDF)

Afloat in a rising sea of type 2 diabetes: Looking for lighthouses in the 4-T trial

Insulin, 2008, Vol.3 (1), p.2-4

Shaefer, Charles F.

2008

Volltextzugriff (PDF)

Is diabetes mellitus ready for the “Do It Yourself” approach?

Insulin, 2007-10, Vol.2 (4), p.154-156

Shaefer, Charles F.

2007

Volltextzugriff (PDF)

Physicians' Corner Advancing Change—Perspectives on Postprandial Glycemia

Insulin, 2007-04, Vol.2 (2), p.50-51

Shaefer, Charles F.

2007

Volltextzugriff (PDF)

The evolving science and practice of insulin therapy

Insulin, 2007-03, Vol.2, p.S1-S3

Shaefer, Charles F.

2007

Volltextzugriff (PDF)

Clinical inertia: Overcoming a major barrier to diabetes management

Insulin, 2006-04, Vol.1 (2), p.61-64

Shaefer, Charles F.

2006

Volltextzugriff (PDF)

A systematic study of molecular vibrational anharmonicity and vibration—rotation interaction by self-consistent-field higher-derivative methods. Asymmetric top molecules

Chemical physics, 1988-07, Vol.123 (2), p.187-239

1988

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(58)
Bücher
(2)
Berichte
(1)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Humans
(24)
Life Sciences & Biomedicine
(24)
Biological And Medical Sciences
(13)
Male
(13)
Adult
(12)
Medical Sciences
(11)
Female
(10)
Middle Aged
(9)
Pharmacology. Drug Treatments
(9)
Drug Therapy, Combination
(7)
Pharmacology & Pharmacy
(7)
Adolescent
(6)
Aged
(6)
Anti-Hiv Agents - Administration & Dosage
(6)
Diabetes
(6)
Drug Administration Schedule
(6)
Hiv Infections - Drug Therapy
(6)
Infectious Diseases
(6)
Abacavir
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Insulin
(14)
Clinical Diabetes
(3)
Hiv Clinical Trials
(3)
Postgraduate Medicine
(3)
Aids
(2)
Gastroenterology
(2)
Annales De Dermatologie Et De Vénéréologie
(1)
Annals Of Internal Medicine
(1)
Arch Oral Biol
(1)
Archives Of Oral Biology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes

User's guide to mechanism of action and clinical use of GLP-1 receptor agonists

Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies

Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus

Commentary: Exenatide QW: A New Treatment Option for Type 2 Diabetes Offering Ease of Use, Improved Efficacy, and Reduced Side Effects

The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin

Weight Change in Patients with Type 2 Diabetes Starting Basal Insulin Therapy: Correlates and Impact on Outcomes

Evaluation of an adrenal mass in a patient with progressive prostate cancer reveals pheochromocytoma

Using a Quantitative Measure of Diabetes Risk in Clinical Practice to Target and Maximize Diabetes Prevention Interventions

LOU064 : un inhibiteur covalent oral de la BTK hautement sélectif et puissant avec des effets pharmacodynamiques prometteurs au niveau de la peau

The Good Old Days Were Not So Good for Inpatient Care

Insulin and Type 2 Diabetes Mellitus Treatment Today: Are We at a Tipping Point?

In search of the holy grail? The quest to reduce macrovascular disease in type 2 diabetes mellitus

The pen is mightier than the sword

The perfect storm?

Shopping for basal insulin on the coffee aisle: Lots of choices for lots of tastes

Implications of the ADA/EASD consensus algorithm for treatment of type 2 diabetes mellitus for primary care practitioners: Four pivotal points

Sunshine on a rainy day: Good news for diabetes

Patient and Physician Barriers to Instituting Insulin Therapy: A Case-Based Overview

Afloat in a rising sea of type 2 diabetes: Looking for lighthouses in the 4-T trial

Is diabetes mellitus ready for the “Do It Yourself” approach?

Physicians' Corner Advancing Change—Perspectives on Postprandial Glycemia

The evolving science and practice of insulin therapy

Clinical inertia: Overcoming a major barrier to diabetes management

A systematic study of molecular vibrational anharmonicity and vibration—rotation interaction by self-consistent-field higher-derivative methods. Asymmetric top molecules

Suchergebnisse filtern